Navigation Links
NOVAVAX Announces Release Date of 2010 Year-End Financial Results and Investor Conference Call
Date:3/23/2011

ROCKVILLE, Md., March 23, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2010 year-end financial results in a press release to be issued after 8:00 a.m. local time Monday, March 28, 2011 and will then hold an investor conference call at 10:00 a.m. The call will be hosted by Novavax's  President and Chief Executive Officer, Dr. Rahul Singhvi and other members of senior management. The dial-in number for the conference call is 1 (877)-212-6076 (U.S. or Canada) or 1 (707)-287-9331 (International).

A live audio webcast of the conference call will be available at www.novavax.com under Investors/Events. A replay of the conference call will be available on Novavax's website approximately one-hour after the event for 90 days and a replay will also be available by telephone beginning March 28, 2011. To access the replay, dial 1-(800)-642-1687 and enter pass code 54520344.

About Novavax

Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company, employs its cutting-edge technology to create next-generation vaccines to prevent serious infectious diseases, such as pandemic and seasonal influenza and respiratory syncytial virus (RSV). The company's proprietary virus-like particles (VLPs) technology and single-use bioprocessing system enables rapid vaccine development and production where and when it's needed, worldwide. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.  


'/>"/>
SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NOVAVAX to Present at BIT Life Sciences 3rd World Congress of Vaccine
2. Maryland Governor Martin OMalley to Visit Novavax in Celebration of HHS-BARDA Contract Award
3. NOVAVAX to Present at Citi 2011 Global Health Care Conference
4. NOVAVAX to Present at 13th Annual BIO CEO & Investor Conference
5. NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
6. NOVAVAX Awarded Nearly $1 Million in Grants from IRS Under Qualifying Therapeutic Discovery Project
7. NOVAVAX to Present at the Immunotherapeutics and Vaccine (IMVAC) Summit
8. NOVAVAX Elects Richard H. Douglas to its Board of Directors
9. Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
10. Novavax Announces Manufacturing Management Appointments
11. Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Scientists at the ... options being tried for mesothelioma may be hampering the research that could lead to ... Click here to read it now. , The team evaluated 98 ...
(Date:5/25/2016)... , ... May 25, 2016 , ... ... Food and Drug Administration (FDA) has granted the company’s orphan drug designation request ... second orphan drug designation granted by the FDA. , Spinocerebellar ataxia is ...
(Date:5/24/2016)... ... ... Last week, Callan Capital, an integrated wealth management firm specializing in asset ... Diego Life Science event at the Estancia La Jolla Resort and Spa. , Over ... Dr. Rich Heyman, former CEO of Aragon and Seragon, and Faheem Hasnain, former CEO ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® ... Farming in 2017 and Beyond. The paper outlines the key trends that are ... industry. , “We’ve witnessed a lot of highs and lows as the precision ...
Breaking Biology Technology:
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):